Federalist Radio Hour
Inside The Study Exposing The Dangers Of Popular Abortion Pill
May 8, 2025
Ryan Anderson, President of the Ethics and Public Policy Center, dives into a groundbreaking study revealing that 11% of women experience serious adverse effects from the abortion pill mifepristone. He discusses alarming safety concerns that challenge the FDA's claims and highlights the diminishing regulations that could jeopardize women's health. The conversation urges the reinstatement of safety measures and informed consent, emphasizing the need for accurate information amid prevalent media narratives.
28:03
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- A recent study reveals that 11% of women face severe complications from mifepristone, significantly higher than the FDA's reported 0.5%.
- The relaxing of safety regulations for mifepristone poses increased risks to women's health, highlighting the need for stringent safety protocols and informed consent.
Deep dives
Adverse Effects of Mifepristone
A recent analysis of insurance claims revealed that approximately 11% of women experience severe complications within 45 days of taking the abortion pill, mifepristone. This statistic contradicts the FDA’s claim that less than 0.5% suffer such adverse effects, indicating a 22-fold increase in risk than previously reported. The analysis used real-world data from over 865,000 insurance claims related to mifepristone abortions, focusing solely on cases related to the drug's use for abortion rather than other purposes. This stark difference in reported complications highlights the critical need for more transparent discussions surrounding the medical risks associated with this widely used abortion method.
